News articles
Charles River recently opened its first location in Chicago, expanding contract vivarium space for the biopharmaceutical industry in Illinois. […]
With $12 million of new funding in hand, Dimension Inx joins other local life sciences companies at the Fulton Market campus. […]
Xeris Biopharma Holdings is bringing its offices and research space under one roof, notching a big win for Chicago’s life sciences scene in the process. […]
The biomedical research facility is a win for Trammell Crow and signals critical mass for life sciences in a neighborhood known for tech companies. […]
Energy Start-Up Celadyne Becomes First Tenant in the Science Ready Lab Suites Trammell Crow Company (TCC), a global commercial real estate developer, today unveiled its Science Ready Lab Suites at Fulton Labs. These fully built out, move-in ready private labs span, 3,000 to 7,000 square feet and provide advanced R&D laboratory space with world-class infrastructure […]
Of the nation’s top 25 life sciences markets, Chicago ranks sixth for job growth. […]
The opportunity for Chicago to develop a thriving life sciences ecosystem is there, and it could pay dividends for the city’s economy if Chicago can become a top-tier biotech town. […]
CHICAGO — March 23, 2021 — Trammell Crow Company (TCC), one of the largest commercial real estate developers in the United States, today announced it has topped out the construction on its Fulton Labs at 400 N. Aberdeen development. The facility is a 423,454 square-foot best-in-class laboratory building that the company is developing to help […]
Judging from the numbers reported by the nation’s top U.S. clusters, 2020 saw record-high amounts of lab space and NIH funding, as well as record-high numbers of jobs and patents. Those highs are reflected in high regional numbers seen in GEN’s annual ranking of the nation’s top 10 biopharma clusters. The pandemic reshuffled the bottom […]
Talis Biomedical, which has filed for a $150 million IPO, is taking 26,000 square feet. […]
